MEDS Latest Press Releases

-- November 9, 2026 --

DataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion Policy ACCESS Newswire 6:00 AM

-- November 5, 2026 --

DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO ACCESS Newswire 6:00 AM

-- November 3, 2026 --

DataMEDS AI Announces Termination of Second Amended and Restated Letter of Intent ACCESS Newswire 6:18 PM

-- November 2, 2026 --

DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee ACCESS Newswire 6:00 AM

-- October 23, 2026 --

DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network ACCESS Newswire 6:45 AM

-- October 22, 2026 --

Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License Business Wire 8:00 AM

DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies ACCESS Newswire 7:40 AM

-- October 20, 2026 --

DataMeds Regains Compliance With NASDAQ Listing Standards ACCESS Newswire 6:00 AM

-- October 16, 2026 --

DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap ACCESS Newswire 6:00 AM

-- October 14, 2026 --

DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform ACCESS Newswire 9:48 AM

-- October 13, 2026 --

DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division ACCESS Newswire 6:00 AM

-- October 12, 2026 --

DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers ACCESS Newswire 6:00 AM

-- October 5, 2026 --

Datameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment ACCESS Newswire 6:00 AM

-- October 1, 2026 --

These Stocks Roar into October with Fresh Catalysts Globe Newswire 12:39 PM

DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue ACCESS Newswire 6:00 AM

-- September 28, 2026 --

4 Explosive Stories Enter the Investor Spotlight Globe Newswire 11:51 AM

DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application ACCESS Newswire 6:00 AM

-- September 25, 2026 --

DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit ACCESS Newswire 6:00 AM

-- September 21, 2026 --

DataMEDS AI Unveils New Corporate Website ACCESS Newswire 6:00 AM

-- September 18, 2026 --

DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked ACCESS Newswire 6:00 AM

-- September 15, 2026 --

DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute ACCESS Newswire 4:05 PM

Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform Globe Newswire 8:30 AM

-- September 8, 2026 --

Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout ACCESS Newswire 6:00 AM

-- August 27, 2026 --

CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM) ACCESS Newswire 9:30 AM

DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM) ACCESS Newswire 8:55 AM

-- August 17, 2026 --

DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update ACCESS Newswire 9:01 AM

-- August 14, 2026 --

DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026 ACCESS Newswire 5:25 PM

-- August 12, 2026 --

DataMeds AI Provides Update on Corexa Health's Pharmacy Division ACCESS Newswire 7:40 AM

-- August 10, 2026 --

DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division ACCESS Newswire 8:30 AM

-- August 6, 2026 --

DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date ACCESS Newswire 8:15 AM

-- August 5, 2026 --

DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here" ACCESS Newswire 8:30 AM

-- July 31, 2026 --

DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM) ACCESS Newswire 8:30 AM

-- July 29, 2026 --

Datavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AI Business Wire 10:18 AM

DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License ACCESS Newswire 10:15 AM

Datavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AI Business Wire 9:05 AM

-- July 27, 2026 --

DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders ACCESS Newswire 9:00 AM

-- July 22, 2026 --

DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets ACCESS Newswire 8:15 AM